Oasis Pharmaceuticals, LLC, is a privately funded start-up consisting of a team of experienced entrepreneurs, exceptional scientists, regulatory specialists, and physicians committed to advancing therapeutic treatments for NASH/metabolic disease, Atopic Dermatitis/pruritus, IBD, HCC, and Acute Stroke.

​

 

We use pepducin chemistry to develop and commercialize novel therapeutics that uniquely target the critical intracellular domains of cell surface receptors.  Our proprietary cell-penetrating pepducin technology will advance a new generation of drugs to effectively treat inflammatory and fibrotic diseases.